|Last Price$10.43||Day Change (%)0.10%|
|Open Price$10.43||Day Change ($)0.01|
|Day Range10.43–10.43||52-Week Range10.41–10.45|
As of Mon 07/27/2015 | USD
Fitch Affirms Allergan's 'BBB-' Ratings Following Generic Business Sale to Teva
Research and Markets: Anal Fissure - Global Clinical Trials Review, H1, 2015
As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.
While more than one third of these top fund managers are outperforming this year, four of them stand out from the rest given their ability to outperform the market over almost all time periods.
Increased investor inflows and portfolio reshuffling (driven in part by a fairly valued market), has added breadth to the high-conviction and new-money purchases we've seen so far from our top managers.